Advertisement
Screener

RA PHARMACEUTICALS, INC. Patents: Applications Rejected

RA PHARMACEUTICALS, INC. Patent Applications Rejected

7 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-07-19: Application 18355092; Invention MODULATORS OF COMPLEMENT ACTIVITY; Applicant Ra Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
  • 2022-03-10: Application 17642096; Invention NEUROLOGICAL DISEASE TREATMENT WITH COMPLEMENT INHIBITORS; Applicant RA PHARMACEUTICALS, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2021-09-23: Application 17442246; Invention Complement Modulators and Related Methods; Applicant Ra Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2021-09-08: Application 17437082; Invention MODULATORS OF COMPLEMENT ACTIVITY; Applicant Ra Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2023-07-1918355092MODULATORS OF COMPLEMENT ACTIVITYRa Pharmaceuticals, Inc.Abandoned -- Incomplete Application (Pre-examination)
Steven James DeMarco
Michelle Denise Hoarty
Grace Victoria Parker
Alonso Ricardo
Sylvia Tobe
Douglas A. Treco
United States
United States
United States
United States
United States
United States
2022-03-1017642096NEUROLOGICAL DISEASE TREATMENT WITH COMPLEMENT INHIBITORSRA PHARMACEUTICALS, INC.Abandoned -- Failure to Respond to an Office ActionUS20220370548A1
Simon J. READ
Alonso RICARDO
Camil SAYEGH
Xiangyang XU
Yalan TANG
Guo-Qing TANG
United States
United States
United States
United States
United States
United States
BRADLEY, CHRISTINA
2021-09-2317442246Complement Modulators and Related MethodsRa Pharmaceuticals, Inc.Abandoned -- Failure to Respond to an Office ActionUS20230115176A1
Willmen Wing-Menn Youngsaye
Bolin Geng
Michael R. Hale
Vincent P. Galullo
Jayashree G. Tikhe
Timothy Ryan Siegert
Alonso Ricardo
Derek M. LaPlaca
Douangsone D. Vadysirisack
Guo-Qing Tang
Kathleen Seyb
Michelle Denise Hoarty
Jonathan C. Blain
Joseph R. Stringer
Yongjin Gong
Claudio Sturino
Shawn Gallagher-Duval
Colin Diner
Burcin Akgun
Qing Cao
Douglas A. Treco
Vaishnavi Rajagopal
Ketki Ashok Dhamnaskar
Zhong Ma
Susan Ashwell
Jennifer Davoren
Xiaorong Liu
Camil Sayegh
Wenqing Xu
Alex Lemire
Audrey Belouin
Alexandria Jeanneret
Andrew Hildering
Barbara Bertani
Fabrizio MIcheli
Bemardo Pezzati
Alfonso Pozzan
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
Canada
Canada
Canada
Canada
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
Canada
Canada
Canada
Canada
Italy
Italy
Italy
Italy
YOO, SUN JAE
2021-09-0817437082MODULATORS OF COMPLEMENT ACTIVITYRa Pharmaceuticals, Inc.Abandoned -- Failure to Respond to an Office ActionUS20220160820A1
Zhong Ma
Nanqun Zhu
Evan Thackaberry
Ramin Farzaneh-Far
Alonso Ricardo
United States
United States
United States
United States
United States
HA, JULIE
2021-04-2217287581NEUROLOGICAL DISEASE TREATMENT WITH ZILUCOPLANRa Pharmaceuticals, Inc.Abandoned -- Failure to Respond to an Office ActionUS20220133841A1
Petra Duda
Ramin Farzaneh-Far
Zhong Ma
Nanqun Zhu
Evan Thackaberry
Alonso Ricardo
United States
United States
United States
United States
United States
United States
AUDET, MAURY A
2020-06-0416769732MODULATORS OF COMPLEMENT ACTIVITYRa Pharmaceuticals, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210000927A1
Alonso Ricardo
Michelle Denise Hoarty
Ramin Farzaneh-Far
United States
United States
United States
FISCHER, JOSEPH
2020-03-1116646263FORMULATIONS FOR COMPOUND DELIVERYRa Pharmaceuticals, Inc.Abandoned -- Failure to Respond to an Office ActionUS20200282024A1
Richard Lee Fahrner
Christian Winthrop Phillips
United States
United States
GITOMER, RALPH J